Deka Bank Deutsche Girozentrale Inhibrx, Inc. Transaction History
Deka Bank Deutsche Girozentrale
- $55.6 Billion
- Q2 2024
A detailed history of Deka Bank Deutsche Girozentrale transactions in Inhibrx, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 26,400 shares of INBX stock, worth $461,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,400
Previous 26,400
-0.0%
Holding current value
$461,735
Previous $918,000
1.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding INBX
# of Institutions
3Shares Held
51.7KCall Options Held
0Put Options Held
0About Inhibrx, Inc.
- Ticker INBX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,057,700
- Market Cap $683M
- Description
- Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...